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Gadolinium-decorated silica microspheres as redox-responsive 
MRI probes for applications in cell therapy follow-up  
M. Muñoz Úbeda,a,† F. Carniato,a,† V. Catanzaro,a,d S. Padovan,b C. Grange,c S. Porta,d C. Carrera,d L. Tei,a and G. Digilioa,*
Abstract: Silica microspheres have been decorated with Gd-
HPDO3A-like complexes through a disulphide bond to obtain a redox-
responsive MRI probe. This probe is designed to be interspersed with 
therapeutic cells within hydrogel capsules, to enable the longitudinal 
follow-up by MRI of the redox microenvironment surrounding the 
embedded cells. 
Cell therapy can be broadly defined as the transplantation of living 
cells for the treatment of a wide number of medical disorders. 
Amongst therapeutic cells, Mesenchymal Stem Cells (MSCs) are 
those most often chosen for pre-clinical studies1 as well as clinical 
trials because of efficacy, safety and lack of ethical issues. 
Although MSCs therapy is poised to establish a new clinical 
paradigm in regenerative medicine, studies completed so far have 
produced mixed results, with overall limited clinical benefits on the 
long term.2 A major challenge to improve cell therapy is to 
enhance long term cell survival by escaping the host immune 
response. For cell therapy applications that require the in situ 
delivery of therapeutic cells (by open surgery or local infusion), a 
viable route to protect cell grafts from immune rejection can be 
the (micro)encapsulation of therapeutic cells within synthetic, 
bioabsorbable hydrogels with engineered extracellular matrix 
(ECM) properties.3 This can provide a shield against recognition 
by either innate and adaptive response. In addition, mimicking a 
native environment around transplanted cells minimizes the 
detrimental effects due to abrupt microenvironment changes that 
follow transplantation. A typical hydrogel forming polymer for cell 
encapsulation is alginate, but several others are under 
investigation, including those based on collagen and hyaluronic 
acid (HA), whose mechanical and physico-chemical properties 
can be tailored to specific applications.4 The cell encapsulation 
approach to deliver cell therapy offers the outstanding possibility 
to add imaging functionalities interspersed with therapeutic cells 
within the capsule, then to enable the longitudinal follow-up by 
imaging techniques of the artificial microenvironment surrounding 
the transplanted cells.5 The basic idea is to incorporate imaging 
probes responsive to ECM properties that can be unambiguously 
linked to the capacity of the artificial microenvironment to support 
cell survival. Extracellular pH (pHe) has been demonstrated to 
decrease appreciably as a consequence of the events related to 
immune-rejection and death of grafted cells. Polyarginine-
containing liposomes as pHe-nanosensors for the CEST-MRI 
modality have been encapsulated with hepatocytes within 
alginate capsules and subcutaneously grafted in mice. The 
decrease of pHe , as monitored by MRI, well correlated with the 
loss of encapsulated cells.6 Redox microenvironment rather than 
pHe may represent a more suitable indicator to assess whether 
the graft is metabolically active or hypoxic. As a matter of facts, a 
key aspect in graft integration into the host is the ability of 
therapeutic cells to recruit a vascular supply of oxygen and 
nutrients to support long-term survival. If neovascularization fails, 
microenvironment hypoxia arises that is expected to correlate 
with poor cell survival. According to this view, we present the 
design, synthesis and characterization of a redox-responsive MRI 
probe to follow-up the redox microenvironment surrounding cells 
embedded within a hydrogel-based matrix. The redox responsive 
probe is composed of porous silica microspheres (SiMSs) whose 
surface has been decorated with i) a Gd-HPDO3A-like chelate 
through a disulfide bond, that provides responsivity to redox 
potential7 (HPDO3A: 1,4,7-tris(carboxymethyl)-10-(2-
hydroxypropyl)-1,4,7,10-tetraazacyclododecane); and ii) 
rhodamine B to allow for multimodal (optical) imaging. These 
particles are designed with size in the micrometer range to ensure 
a stable entrapment within the synthetic extracellular matrix. 
Within the planned application, Gd labelled SiMSs (shortly, Gd-
SiMSs) interspersed with therapeutic cells should cause a bright 
contrast within the hydrogel phase in T1- weighted MR images 
(Scheme 1). Responsivity to redox microenvironment is achieved 
by pharmacokinetic modulation: increasingly reducing conditions 
are expected to shift the disulphide/thiol redox equilibrium 
towards the thiol form,8 ultimately resulting in the release of the 
low molecular weight Gd-chelate in the thiol form (Gd-SH; see 
Scheme 2). As Gd-SH is small and neutral, it is expected to 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1. Rationale for the use of Gd-SiMSs as redox-responsive MRI probes 
to follow-up the survival of encapsulated cells. 
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Scheme 2. Schematic view of the synthesis of bimodal redox-responsive silica 
microspheres (Gd-SiMS). 
 
 
 
 
 
 
 
 
Figure 1. HR-TEM micrographs of SiMS at low (A) and high (B) magnifications. 
 
diffuse out the hydrogel phase causing a progressive decrease of 
T1 contrast enhancement. 
Silica microspheres were prepared through a sol–gel synthesis, 
by adapting a procedure reported in the literature.9 Particles with 
spherical shape and size of ca. 1 μm (as indicated by TEM 
micrographs, Fig. 1A) were obtained. Micrographs collected at 
higher magnifications (Fig. 1B) indicate the presence of a pore 
array, whose evidence is strengthened by N2 physisorption 
analysis (Fig. S1). The sample shows a pore-size distribution with 
maximum at 5 nm and pores volume of 0.71 cm3/g.  
The silica surface was functionalized with amino and thiol groups, 
through simultaneous reaction of silica particles with 
aminopropyltriethoxysilane and mercaptopropyltrimethoxysilane 
in toluene suspension (see SI). A marked reduction of the pores 
volume of ca. 60% occurred as a consequence of the surface 
functionalization (Fig. S1). Functional groups are randomly 
distributed both inside the pores and on the external surface of 
silica particles. The presence of –NH2 and –SH groups on silica 
surface was confirmed by the characteristic IR absorptions falling 
at 3370 and 3300 cm-1 (asymmetric and symmetric stretching 
mode of –NH2 groups), and at 2570 cm-1 (stretching mode of –SH, 
Fig. S2). The amount of amino and thiol groups was 1.05 mmol/g 
and 0.39 mmol/g, respectively, as determined by CHNS  
 
 
 
 
 
 
 
Figure 2. (A) 1H NMRD profiles of aqueous solutions of Gd-PDP (Δ) and Gd-
SiMS (●) at 37 °C. The best-fit curves were calculated using the parameters of 
Table S1. (B) Kinetics of the reduction of the Gd-SiMS disulfide bond by TCEP 
([Gd] = 0.4 mM; [TCEP] = 0.4 mM) followed by R1 measurement at 20 MHz and 
25°C.  
elemental analysis. The bimodal Gd-SiMS system was then 
obtained following two consecutive synthetic steps (Scheme 2). 
The first one consists on linking a Gd-chelate to the silica thiol 
groups with the formation of the redox-responsive disulfide. To 
this purpose, compound Gd-PDP bearing the thiol-reactive 2-
pyridyl-dithio group was synthesized. This novel compound is 
based on the macrocyclic octadentate HPDO3A chelating cage, 
which ensures higher chemical inertness,10a higher catabolic 
stability10b and low cell penetrating potential10c as compared to 
available heptadentate DO3A complexes or linear complexes. 
The conjugation of Gd-PDP to the free thiols on the silica surface 
was carried out in water at RT for 4 hrs by monitoring the release 
of 2-pyridine-thione at 343 nm (molar absorptivity of 8081 M-1cm-
1).7a The amount of Gd in the final material was estimated to be 
0.04 mmol/g, as found by inductively coupled plasma optical 
emission spectrometry (ICP-OES) gadolinium analysis. The 
chemical linkage of rhodamine B isothiocyanate to a fraction of 
the –NH2 functionalities located on the surface was performed in 
acetonitrile in the presence of N,N-Diisopropylethylamine. The 
amount of rhodamine B bound to the silica surface was 0.035 
mmol/g, as estimated by UV/Vis spectroscopy (Fig. S3). After 
these conjugation reactions, particles with surface charge density 
of +10 mV in aqueous solution (data from Z-potential analysis), 
arising from surface free -NH3+, were obtained. 
The electronic properties of the obtained bimodal silica 
microspheres (dubbed Gd-SiMSs) were investigated by UV/Vis 
and photoluminescence spectroscopy (Fig. S4). The UV/Vis 
spectrum of pure rhodamine in water shows an absorption 
maxima typical of π→π* transitions (λ = 530 and 562 nm).11 The 
same bands are also found after dye coupling to silica surface, 
although slightly shifted to higher wavelengths and with a different 
intensity ratio as a consequence of a different chemical 
environment. The PL spectra of the free dye and the conjugated 
system display an emission band with a maximum at 577 and 583 
nm, respectively (Fig. S4). 
The relaxation properties of Gd-SiMSs were studied by recording 
the 1H nuclear magnetic relaxation dispersion (NMRD) profile in 
the frequency range 0.01 to 70 MHz at 37 °C (Fig. 2A). NMRD 
profiles report water proton relaxation rates R1 (R1=1/T1) as a 
function of the magnetic field strength. To avoid particle 
sedimentation (at least for 24 hrs; Fig. S5), Gd-SiMSs were 
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suspended in aqueous xanthan gum (0.1 wt%). The 1H NMRD 
profile of Gd-SiMSs show a broad relaxivity peak centered at 
about 20-30 MHz (r1 = 5.7 mM-1s-1 per Gd ion at 20 MHz), followed 
by a relaxivity dispersion at higher fields. This is typical of slowly 
tumbling macromolecular systems.12 The NMRD profile was fitted 
according to the conventional paramagnetic relaxation model 
(based on Solomon-Bloembergen-Morgan and Freed’s 
theories)13 implemented with the Lipari–Szabo model-free 
approach14, that accounts for relatively fast local motions 
superimposed to the global, slow microparticle motion 
(characterized by correlation times τRL and τRG , respectively). 
Best fitting yields a τRL value of 8.9 ns. Such a value is significantly 
longer than that of the free Gd-chelate (τR = 80 ps) indicating a 
slowing down of re-orientation dynamics, but the order parameter 
S2=0.62 also indicates that there is a significant decoupling 
between global and local motions (full fitting parameters are 
available in SI). This is due to the flexibility of the linker connecting 
the Gd-chelate to the particle surface. As a result of unrestricted 
local flexibility, the NMRD relaxivity peak has a low amplitude. At 
20 MHz and 37°C the relaxivity of Gd-SiMSs is 30% higher than 
that of the precursor Gd-PDP. On the other hand, except for the 
magnetic field range corresponding to the relaxivity peak, the 
NMRD profile of Gd-SiMSs shows somewhat lower relaxivities 
than Gd-PDP. This is likely due to the fact that a fraction of the 
Gd-chelates is located within particle pores, where the relaxivity 
is limited by poor water diffusion. In this regard, Gd-SiMS is very 
similar to other Gd-decorated mesoporous silicas reported in the 
literature.15  
To assess the responsivity of the MRI probe to reducing agents, 
tris(2-carboxyethyl)phosphine (TCEP) was added to a 
suspension of Gd-SiMSs at neutral pH and the longitudinal 
relaxation rate was monitored over time at 20 MHz and 25 °C (Fig. 
2B). At this magnetic field, the reductive cleavage of the disulfide 
bond can be followed by the 30% change of relaxivity due to the 
loss of the macromolecule effect ongoing from the Gd-SiMS to the 
Gd-SH form. The kinetics of release of the free Gd-SH complex is 
comparable to that of other published disulphide-based Gd 
compounds 7b,c. This rules out any steric effect possibly interfering 
with the reductive cleavage, such as poor accessibility of the 
disulphide bridge within silica pores.  
To mimic the clearance of contrast from the synthetic tissue, Gd-
SiMSs were suspended into 1% agar and the gel was kept in 
contact under gentle shaking with a 200-fold excess volume of 
buffer (see SI Scheme S1). Such buffer contained or not 50 mM 
GSH. Axial T1w-MR images were taken at several time points 
across the agar phase (Fig. 3). In the presence of GSH, the 
reductive cleavage of the disulfide bond and clearance of Gd-SH 
from the agar phase into the buffer took place, leading to the 
almost complete drop of signal enhancement in the agar phase, 
as expected. 
The biocompatibility has been assessed by incubating hMSCs 
with Gd-SiMSs up to 12 days and by evaluating cell viability, 
proliferation rate and morphology. Adverse effects were found at 
a particle-to-cell ratio of 6.6 ngGd-SiMS/cell, together with a 
significant particle uptake into the cytoplasm. Despite the large 
 
 
 
 
 
 
 
Figure 3. T1w MRI at 7 T (300 MHz) of Gd-SiMSs suspended in agar phantoms 
before (A) and after 7-days washings (B) with a buffer containing (+ GSH) or 
not glutathione (- GSH). The agar phantom without Gd-SiMSs is labelled “ref”. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. False color parametric images obtained from T1w MRI at 7 T (300 
MHz). (A) Signal Enhancement maps normalized by the SE at t=0 (SE%) of a 
phantom containing Gd-SiMSs/HA interspersed with hMSCs within a matrigel 
matrix under normoxia or reducing conditions. Each well was incubated in 
conditions that allow for the diffusion of the Gd-SH complex out of the hydrogel 
phase. The phantom labelled “ref” contains HA/Matrigel only (no Gd, no cells). 
(B) Time-evolution of the normalized SE with incubation time (days) as 
calculated from T1w MR images (error bars are SEM over three slices; the 
asterisks indicate statistical significance according to the Student t-test). 
particle size (ca. 1 μm), internalization still occurs because of the 
slight cationic charge of particles. However, pre-mixing of Gd- 
SiMSs with strongly anionic HA (1:1 w/w) to shield excess positive 
charge and dispersion of the Gd-SiMS/HA system with hMSC 
within a gelatin-based hydrogel (BD MatrigelTM) abolished 
adverse effects up to a particle-to-cell ratio of 40 ngGd-SiMS/cell, 
while providing a stable labelling of the synthetic extracellular 
microenvironment. 
Finally, Gd-SiMS were assessed for their ability to report about 
the extracellular redox microenvironment within a gelatin/HA 
hydrogel embedding hMSCs. Cells were interspersed with Gd-
SiMSs within the hydrogel at a cell density of 400 cells/L, 
particle-to-cell ratio of 30 ngGd-SiMS/cell, and total Gd concentration 
of 50 M. The cell-embedding hydrogel (100 L) was kept in 
contact with 150 L of culture medium and incubated at 37°C 
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under conditions simulating either a normoxic or a highly reducing 
extracellular microenvironment (hypoxia and 30 mM reduced 
glutathione). Such a two-phase system (see SI Scheme S2) was 
conceived as a the simplest way to mimic clearance of reduced 
Gd-SH from the hydrogel phase, that is strictly needed to achieve 
the pharmacokinetic modulation of the signal enhancement as 
sketched in Scheme 1. T1w MR images at 7 T were taken across 
the hydrogel phase at regular time intervals over 9 days. Signal 
intensities within MR images were transformed into Signal 
Enhancements (SE) with reference to the Gd-free HA/collagen 
hydrogel and normalized to the SE obtained at t=0 (Fig. 4). The 
parametric images show that the SE% drop in the reducing 
hydrogel becomes significantly higher than that of normoxia since 
day-2, and approaches 54% at day 9 (note that 60% is the 
maximum drop achievable by our experiment design, see SI 
Scheme S2). The difference in the signal drop is maintained 
throughout the whole experiment duration, even though some 
drop of the absolute SE% is noted also for the normoxia hydrogel 
at endpoint day-9. This is likely due to remodeling/degradation of 
the gelatin matrix, that creates time-fluctuating, heterogeneous 
spots of Gd-SiMS aggregation within the hydrogel (see Fig. 4A). 
This is a source of experimental uncertainty of SE measurements. 
Cell viability was evaluated at day-9 by the assessment of the 
proliferation and morphology of cells within the hydrogels. Live 
cells were found in the normoxia hydrogel, but not in the reducing 
one (Fig. S6). Thus, it is concluded that the assessment of the 
extracellular redox state as a marker of its capacity to sustain 
cell survival cannot rely on measurements at a single time 
point. Instead, the persistency of high redox potential along 
an extended period of time is a more reliable indicator of 
progressive cell loss. 
In conclusion, this work shows for the first time the application of 
redox-responsive, silica based microparticles as MRI probes for 
the longitudinal follow-up of the redox microenvironment within an 
artificial extracellular matrix. The next step prior to proceed to in 
vivo studies deals with the optimization of Gd-SIMS surface 
properties to minimize time-dependent particle aggregation driven 
by hydrogel remodeling, to enhance both biocompatibility and 
sensitivity. This can be pursued, for instance, by decorating the 
particle surface with polyethylene glycol chains and/or by fine 
tuning of particle surface charge. 
Experimental Section 
Synthesis of SiMS and derived materials: SiMS particles were prepared 
through a sol-gel procedure, calcined in air and functionalized with 
aminopropyl (25 wt%) and 3-Mercaptopropyl-alkoxysilanes (25 wt%) in 
toluene. Finally, the surface of the organo-modified sample was decorated 
with a Gd-HPDO3A-like complex and rhodamine B isothiocyanate. MR 
images were acquired with a Bruker Avance microimaging MR scanner 
operating at 7T. Further experimental details are available online. 
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